Home
/
WEST PHARMACEUTICAL SERVICES INC
/
Financials
/
Quarterly
WEST PHARMACEUTICAL SERVICES INC — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that WEST PHARMACEUTICAL SERVICES INC filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2024
Mar 31, 2024
$695.40M
Apr 25, 2024
Q1
2024
Mar 31, 2023
$716.60M
Apr 25, 2024
Q1
2023
Mar 31, 2022
$720.00M
Apr 27, 2023
Q1
2022
Mar 31, 2021
$670.70M
Apr 28, 2022
Q1
2021
Mar 31, 2020
$491.50M
Apr 30, 2021
Q3
2019
Sep 30, 2019
$456.10M
Oct 29, 2019
Q2
2019
Jun 30, 2019
$469.70M
Jul 29, 2019
Q1
2020
Mar 31, 2019
$443.50M
Apr 24, 2020
Q3
2019
Sep 30, 2018
$431.70M
Oct 29, 2019
Q2
2019
Jun 30, 2018
$447.50M
Jul 29, 2019
Q1
2019
Mar 31, 2018
$415.70M
May 8, 2019
Q3
2018
Sep 30, 2017
$398.20M
Oct 30, 2018
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$804.60M
Oct 23, 2025
Q2
2025
Jun 30, 2025
$766.50M
Jul 24, 2025
Q1
2025
Mar 31, 2025
$698.00M
Apr 24, 2025
Q3
2025
Sep 30, 2024
$746.90M
Oct 23, 2025
Q2
2025
Jun 30, 2024
$702.10M
Jul 24, 2025
Q1
2025
Mar 31, 2024
$695.40M
Apr 24, 2025
Q3
2024
Sep 30, 2023
$747.40M
Oct 24, 2024
Q2
2024
Jun 30, 2023
$753.80M
Jul 25, 2024
Q1
2024
Mar 31, 2023
$716.60M
Apr 25, 2024
Q3
2023
Sep 30, 2022
$686.90M
Oct 26, 2023
Q2
2023
Jun 30, 2022
$771.30M
Jul 27, 2023
Q1
2023
Mar 31, 2022
$720.00M
Apr 27, 2023
Q3
2022
Sep 30, 2021
$706.50M
Oct 27, 2022
Q2
2022
Jun 30, 2021
$723.60M
Jul 28, 2022
Q1
2022
Mar 31, 2021
$670.70M
Apr 28, 2022
Q3
2021
Sep 30, 2020
$548.00M
Oct 28, 2021
Q2
2021
Jun 30, 2020
$527.20M
Jul 30, 2021
Q1
2021
Mar 31, 2020
$491.50M
Apr 30, 2021
Q3
2020
Sep 30, 2019
$456.10M
Oct 23, 2020
Q2
2020
Jun 30, 2019
$469.70M
Jul 24, 2020
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2018
Jun 30, 2018
$447.50M
Jul 31, 2018
Q1
2018
Mar 31, 2018
$415.70M
May 8, 2018
Q3
2017
Sep 30, 2017
$398.20M
Oct 31, 2017
Q2
2018
Jun 30, 2017
$397.60M
Jul 31, 2018
Q1
2018
Mar 31, 2017
$387.70M
May 8, 2018
Q3
2017
Sep 30, 2016
$376.70M
Oct 31, 2017
Q2
2017
Jun 30, 2016
$388.00M
Aug 1, 2017
Q1
2017
Mar 31, 2016
$362.10M
May 5, 2017
Q3
2016
Sep 30, 2015
$344.50M
Oct 31, 2016
Q2
2016
Jun 30, 2015
$359.70M
Aug 1, 2016
Q1
2016
Mar 31, 2015
$335.90M
May 6, 2016
Q3
2015
Sep 30, 2014
$355.90M
Nov 2, 2015
Q2
2015
Jun 30, 2014
$368.90M
Aug 3, 2015
Q1
2015
Mar 31, 2014
$346.80M
May 6, 2015
Q3
2014
Sep 30, 2013
$341.80M
Nov 3, 2014
Q2
2014
Jun 30, 2013
$344.50M
Aug 1, 2014
Q1
2014
Mar 31, 2013
$339.40M
May 8, 2014
Q3
2013
Sep 30, 2012
$303.80M
Nov 4, 2013
Q2
2013
Jun 30, 2012
$324.80M
Aug 5, 2013
Q1
2013
Mar 31, 2012
$316.30M
May 6, 2013
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$140.00M
Oct 23, 2025
Q2
2025
Jun 30, 2025
$131.80M
Jul 24, 2025
Q3
2025
Jun 30, 2025
$131.80M
Oct 23, 2025
Q1
2025
Mar 31, 2025
$89.80M
Apr 24, 2025
Q3
2025
Mar 31, 2025
$89.80M
Oct 23, 2025
Q2
2025
Mar 31, 2025
$89.80M
Jul 24, 2025
Q3
2025
Sep 30, 2024
$136.00M
Oct 23, 2025
Q2
2025
Jun 30, 2024
$111.30M
Jul 24, 2025
Q3
2025
Jun 30, 2024
$111.30M
Oct 23, 2025
Q1
2025
Mar 31, 2024
$115.30M
Apr 24, 2025
Q2
2025
Mar 31, 2024
$115.30M
Jul 24, 2025
Q3
2025
Mar 31, 2024
$115.30M
Oct 23, 2025
Q3
2024
Sep 30, 2023
$161.30M
Oct 24, 2024
Q2
2024
Jun 30, 2023
$155.10M
Jul 25, 2024
Q3
2024
Jun 30, 2023
$155.10M
Oct 24, 2024
Q3
2024
Mar 31, 2023
$140.00M
Oct 24, 2024
Q2
2024
Mar 31, 2023
$140.00M
Jul 25, 2024
Q1
2024
Mar 31, 2023
$140.00M
Apr 25, 2024
Q3
2023
Sep 30, 2022
$120.60M
Oct 26, 2023
Q2
2023
Jun 30, 2022
$188.50M
Jul 27, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$167.60M
Oct 23, 2025
Q2
2025
Jun 30, 2025
$153.70M
Jul 24, 2025
Q1
2025
Mar 31, 2025
$107.00M
Apr 24, 2025
Q3
2025
Sep 30, 2024
$161.30M
Oct 23, 2025
Q2
2025
Jun 30, 2024
$126.20M
Jul 24, 2025
Q1
2025
Mar 31, 2024
$122.80M
Apr 24, 2025
Q3
2024
Sep 30, 2023
$177.30M
Oct 24, 2024
Q2
2024
Jun 30, 2023
$182.50M
Jul 25, 2024
Q1
2024
Mar 31, 2023
$155.30M
Apr 25, 2024
Q3
2023
Sep 30, 2022
$186.20M
Oct 26, 2023
Q2
2023
Jun 30, 2022
$228.40M
Jul 27, 2023
Q1
2023
Mar 31, 2022
$189.70M
Apr 27, 2023
Q3
2022
Sep 30, 2021
$181.40M
Oct 27, 2022
Q2
2022
Jun 30, 2021
$211.30M
Jul 28, 2022
Q1
2022
Mar 31, 2021
$175.60M
Apr 28, 2022
Q3
2021
Sep 30, 2020
$99.20M
Oct 28, 2021
Q2
2021
Jun 30, 2020
$103.60M
Jul 30, 2021
Q1
2021
Mar 31, 2020
$88.00M
Apr 30, 2021
Q3
2020
Sep 30, 2019
$67.30M
Oct 23, 2020
Q2
2020
Jun 30, 2019
$80.50M
Jul 24, 2020